Safety and Efficacy of Bupropion Combined with Bromocriptine for Treatment of Cocaine Dependence

References

• Ritz M C, Lamb R J, Goldberg S R, et al. Cocaine self‐administration appears to be mediated by dopamine uptake inhibition. Prog Neuropsychopharmacol Biol Psychiatry 1988; 12: 233–239
   Google Scholar
• VoIkow N D, Fowler J S, Wolf A P, et al. Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry 1990; 147: 719–724
   Google Scholar
• Dackis C H, Gold M S. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 1985; 9: 469–477
   PubMed Web of Science ®Google Scholar
• Wyatt R J, Karoum F, Suddath R. Persistently decreased brain dopamine levels and cocaine (letter). JAMA 1988; 27: 2996
   Google Scholar
• Ferris R M, Cooper B R, Maxwell R A. Some studies of bupropion's mechanism of antidepressant activity. J Clin Psychiatry 1983; 55: 74–78
   Google Scholar
• Margolin A, Kosten T, Petrakis I, et al. Bupropion reduces cocaine abuse in methadone‐maintained patients (letter). Arch Gen Psychiatry 1991; 48: 87
   PubMed Web of Science ®Google Scholar
• Vance M L, Evans W S, Thorner M O. Bromocriptine. Ann Intern Med 1984; 100: 78–91
   PubMed Web of Science ®Google Scholar
• Roehrich H, Dackis C A, Gold M S. Bromocriptine. Med Res Rev 1987; 7: 243–269
   Google Scholar
• Lieberman A N. Treatment of Parkinson's disease. Mayo Clin Proc 1988; 63: 1046–1049
   PubMedGoogle Scholar
• Dackis C A, Gold M S. Bromocriptine as a treatment of cocaine abuse (letter). Lancet 1985; 1: 1151–1152
   PubMed Web of Science ®Google Scholar
• Giannini A J, Baumgartel P, DiMarzio L R. Bromocriptine therapy in cocaine withdrawal. J Clin Pharmacol 1987; 27: 267–270
   PubMed Web of Science ®Google Scholar
• Dackis C A, Gold M S, Sweeney D R. Single‐dose bromocriptine reverses cocaine craving. Psychiatry Res 1989; 29: 11–16
   Google Scholar
• Dackis C A, Gold M S, Davies R K. Bromocriptine treatment for cocaine abuse: the dopamine depletion hypothesis. Int J Psychiatry Med 1985; 15: 125–135
   PubMed Web of Science ®Google Scholar
• Giannini A J, Folts D J, Feather J N, et al. Bromocriptine and amantadine in cocaine detoxification. Psychiatry Res 1989; 29: 11–16
   PubMed Web of Science ®Google Scholar
• Giannini A J, Billet W. Bromocriptine‐desipramine protocol in treatment of cocaine addiction. J Clin Pharmacol 1987; 27: 549–554
   PubMed Web of Science ®Google Scholar
• Gold M S, Gross D A, Extein I L. Bromocriptine treatment of cocaine withdrawal symptoms (letter). Am J Psychiatry 1989; 146: 403
   Google Scholar
• Tennant F S, Sagherian A A. Double‐blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Arch Intern Med 1987; 147: 109–112
   PubMed Web of Science ®Google Scholar
• Moscovitz H, Brookoff D, Nelson L. A randomized trial of bromocriptine for cocaine users presenting to the emergency department. J Gen Intern Med 1993; 8: 1–4
   PubMed Web of Science ®Google Scholar
• Teller D W, Devenyi P. Bromocriptine in cocaine withdrawal–Does it work?. Int J Addict 1988; 23: 1197–1205
   PubMed Web of Science ®Google Scholar
• Kumor K, Sherer M, Jaffe J. Effects of bromocriptine pretreatment on subjective and physiological response to IV cocaine. Pharmacol Biochem Behav 1989; 33: 829–337
   PubMed Web of Science ®Google Scholar
• Nunes E V, McGrath P J, Stewart J W, et al. Bromocriptine treatment for cocaine addiction. American Journal on Addiction 1993; 2: 169–172
   Google Scholar
• Kranzler H R, Bauer L O. Bromocriptine and cocaine cue reactivity in cocaine‐dependent patients. Br J Addict 1992; 87: 1537–1548
   PubMedGoogle Scholar
• Preston K L, Sullivan J T, Strain E C, et al. Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers. J Pharmacol Exp Ther 1992; 262: 279–291
   Google Scholar
• Zimmerman T, Sage J I. Comparison of combination of pergolide and levodopa to levodopa alone after 63 months of treatment. Clin Neuropharma‐col 1991; 14: 165–169
   Google Scholar
• Fischer P A, Przuntek H, Majer M, et al. Combined treatment of early stages of Parkinson's syndrome with bromocriptine and levodopa: a multi‐center evaluation. Deutsche Medizinische Wochen‐schrift 1984; 109: 1279–1283
   PubMedGoogle Scholar
• Rinne U K. Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5‐year follow‐up. Neurology 1987; 37: 826–828
   PubMed Web of Science ®Google Scholar
• Helzer J, Croughan J, Robins L, et al. National Institute of Mental Health Diagnostic Interview Schedule: its history, characteristics, and validity. Arch Gen Psychiatry 1981; 38: 381–389
   Google Scholar
• Rounsaville B J, Gawin F H, Kleber H D. Interpersonal psychotherapy adapted for ambulatory cocaine abusers. Am J Drug Alcohol Abuse 1985; 11: 171–191
   PubMed Web of Science ®Google Scholar
• Beck A T, Ward C H, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 53–63
   Web of Science ®Google Scholar
• Cone E J, Dickerson S L. Efficacy of urinalysis in monitoring heroin and cocaine abuse patterns: implications in clinical trials for treatment of drug dependence. NIDA Res Monogr 1992; 128: 46–58
   PubMedGoogle Scholar
• Hawks R L. Analytical methodology. NIDA Res Monogr 1986; 73: 30–42
   PubMedGoogle Scholar
• Jain R B. Design of clinical trials for treatment of opiate_dependence: what is missing?. NIDA Res Monogr 1992; 128: 29–36
   PubMedGoogle Scholar
• Montoya I D, Levin F R, Fudala P J, et al. Double‐blind comparison of carbamazepine and placebo for treatment of cocaine dependence. Drug Alcohol Depend 1995; 38: 213–219
   PubMed Web of Science ®Google Scholar
• Covi L, Hess J M, Kreiter N A, et al. Effects of combined fluoxetine and counseling in die outpatient treatment of cocaine abusers. Am J Drug Alcohol Abuse 1995; 21: 327–344
   PubMed Web of Science ®Google Scholar
• Covi L, Hess J M, Kreiter N A. Psychodierapy dosage effects in cocaine dependence (abstract). Proceedings of die American Psychiatric Association 146th Annual Meeting. 1993; 53
   Google Scholar
• Ho K Y, Thorner M O. Therapeutic applications of bromocriptine in endocrine and neurological diseases. Drugs 1988; 36: 67–82
   PubMed Web of Science ®Google Scholar
• Kosten T R, Schumann B, Wright D. Bromocriptine treatment of cocaine abuse in patients maintained on methadone. Am J Psychiatry 1988; 145: 382–383
   Google Scholar
• Cocores J A, Patel M D, Gold M S, et al. Cocaine abuse, attention deficit disorder, and bipolar disorder. J Nerv Ment Dis 1987; 175: 431–432
   PubMed Web of Science ®Google Scholar
• Dackis C A, Gold M S. Bromocriptine treatment of cocaine addiction. Psychiatry Letter 1985; 3: 45–50
   Google Scholar